Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Exercise or conversion Vice President-Finance & CFO acquired 70,000 shares (option exercise)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Director bought 100,000 shares
  14. 4 Open-market buy Director bought 100,000 shares
  15. 4 Open-market buy Chief Operating Officer bought 800,000 shares
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Exercise or conversion VP-Finance & CFO acquired 5,000 shares (option exercise)
  19. 4 Open-market buy Director bought 100,000 shares at an average $0.28 ($28,085)
  20. 4 Open-market buy Director bought 105,000 shares at an average $0.29 ($30,150)

Page 17 of 24 · 471 filings